Nan Li

Development and optimization of CAR T cells targeting glypican-1 for pancreatic cancer therapy. nature.com/articles/s4146… #CancerResearch @natrescancer @MitchellHo @NanLizea @theNCI @NCIResearchCtr @IRPatNIH

At #AACR22 Nan Li @NanLizea and Dan Li @danli_502 presented work from our lab on #nanobody-based CAR T cells targeting GPC1 in #PancreaticCancer and PD-L1 @NCIResearchCtr